Tipo de artículo
Condición
Encuadernación
Más atributos
Ubicación del vendedor
Valoración de los vendedores
Publicado por Frankfurt [Main] : Bundesverb. d. Pharmazeut. Industrie, 1982
Librería: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Alemania
Libro
Softcover. 19 S. ; 20 x 21 cm Guter Zustand. Leseseiten sind sauber und ohne Markierungen. Ausgeschiedenes Bibliotheksexemplar mit entsprechender Kennzeichnung. Buch weist leichte Lager- bzw. Gebrauchsspuren auf. Sonst gutes Exemplar. Sprache: Deutsch Gewicht in Gramm: 1000.
Publicado por Springer-Verlag, 1989
ISBN 10: 3540505342ISBN 13: 9783540505341
Librería: Anybook.com, Lincoln, Reino Unido
Libro
Condición: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean From Markings. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,700grams, ISBN:3540505342.
Publicado por Springer-Verlag GmbH, 1991
ISBN 10: 3540535055ISBN 13: 9783540535058
Librería: NEPO UG, Rüsselsheim am Main, Alemania
Libro
Gebundene Ausgabe. Condición: Sehr gut. 338 Seiten ex library book / aus einer Unternehmensbibliothek Sprache: Englisch Gewicht in Gramm: 550.
Publicado por Springer-Verlag GmbH, 1991
ISBN 10: 3540535055ISBN 13: 9783540535058
Librería: NEPO UG, Rüsselsheim am Main, Alemania
Libro
Gebundene Ausgabe. Condición: Sehr gut. 338 Seiten ex LIbrary 'Book / aus einer wissenschaftlichen Bibliothek/ Sprache: Englisch Gewicht in Gramm: 550.
Publicado por Bern ; Frankfurt am Main ; New York ; Paris : Lang, 1989
ISBN 10: 3261041609ISBN 13: 9783261041609
Librería: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Alemania
Libro
Broschiert. 102 S. ; 24 cm Guter Zustand. Leseseiten sind sauber und ohne Markierungen. Ausgeschiedenes Bibliotheksexemplar mit den üblichen Kennzeichnungen. Buch weist leichte Lagerspuren bzw. Gebrauchsspuren auf. Sonst gutes Exemplar. 9783261041609 Sprache: Deutsch Gewicht in Gramm: 200.
Publicado por Springer-Verlag, 1989
ISBN 10: 3540505342ISBN 13: 9783540505341
Librería: Reader's Corner, Inc., Raleigh, NC, Estados Unidos de America
Libro Original o primera edición
Cloth. Condición: Fine. No Jacket. First Edition. This is a fine, unmarked, hardcover first edition copy, blue cloth binding, no DJ.
Publicado por Bern ; Frankfurt am Main ; New York ; Paris : Lang, 1990
ISBN 10: 3261043016ISBN 13: 9783261043016
Librería: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Alemania
Libro
Kartoniert. 127 S.; 11 Abb., 29 Tab. Sehr guter Zustand. Leseseiten sind sauber und ohne Markierungen. Ausgeschiedenes Bibliotheksexemplar mit den üblichen Kennzeichnungen. Buch weist leichte Lagerspuren auf. Sonst sehr gutes Exemplar. 9783261043016 Sprache: Deutsch Gewicht in Gramm: 500.
Publicado por Springer-Verlag GmbH, 1989
ISBN 10: 3540505342ISBN 13: 9783540505341
Librería: NEPO UG, Rüsselsheim am Main, Alemania
Libro
Gebundene Ausgabe. Condición: Sehr gut. 216 Seiten ex LIbrary 'Book / aus einer wissenschaftlichen Bibliothek/ Sprache: Englisch Gewicht in Gramm: 550.
Publicado por Springer, 1991
ISBN 10: 3540535055ISBN 13: 9783540535058
Librería: Books Puddle, New York, NY, Estados Unidos de America
Libro
Condición: New. pp. xxi + 338 1st Edition.
Publicado por Springer 16.01.1989., 1989
ISBN 10: 3540505342ISBN 13: 9783540505341
Librería: AMAHOFF- Bookstores, Roßtal, Alemania
Libro
Condición: Sehr gut. Auflage: 1. 240 Seiten Sehr gutes Exemplar 55 9783540505341 Sprache: Englisch Gewicht in Gramm: 626 0,0 x 0,0 x 0,0 cm, Gebundene Ausgabe.
Publicado por Springer, 1991
ISBN 10: 3540535055ISBN 13: 9783540535058
Librería: Majestic Books, Hounslow, Reino Unido
Libro
Condición: New. pp. xxi + 338 35 Figures.
Publicado por Springer, 2011
ISBN 10: 3642742742ISBN 13: 9783642742743
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Libro
Soft Cover. Condición: new.
Publicado por Springer, 2011
ISBN 10: 3642742742ISBN 13: 9783642742743
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer, 2011
ISBN 10: 3642742742ISBN 13: 9783642742743
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Libro Impresión bajo demanda
Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Publicado por Springer, 1991
ISBN 10: 3540535055ISBN 13: 9783540535058
Librería: Mispah books, Redhill, SURRE, Reino Unido
Libro
Hardcover. Condición: Like New. Like New. book.
Publicado por Springer Berlin Heidelberg Dez 2011, 2011
ISBN 10: 3642742742ISBN 13: 9783642742743
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Libro Impresión bajo demanda
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public. 240 pp. Englisch.
Publicado por Springer Berlin Heidelberg Sep 2011, 2011
ISBN 10: 3642647626ISBN 13: 9783642647628
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Libro Impresión bajo demanda
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety In April 1990, this question became the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance. Called an 'international dialogue conference' by its organizers, the meeting brought together leaders from the pharmaceutical industry, regulatory authorities, academia, medicine, consumer organizations and the media. Opening addresses were given by representatives of the Council for International Organizations of Medical Sciences (CIOMS), the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), the Swiss International Pharmaceutical Agency, and the RAD-AR Consortium. This book documents the papers presented and discussions held at this conference, which took the topic of risks and benefits of drug therapy one step further to responsibility. It includes a rich menu of issues for those who care about the evaluation of drug therapy, the ethics behind it, the expectations of the patient, and the role of traditional and nontraditional drug safety communica tions. The ideas expressed here come from different parts of the world but relate to common drug safety problems, observations, and scientific assessments; they provide insights into innovative approaches, cautious changes, and desired actions. The papers in this volume are broadly divided into conceptual perspectives (ethics, how the knowledge about drug risks and benefits is generated and appraised, the expectations in drug safety) and operational perspectives (communication, discussion, and action). 364 pp. Englisch.
Publicado por Springer Berlin Heidelberg, 2011
ISBN 10: 3642742742ISBN 13: 9783642742743
Librería: moluna, Greven, Alemania
Libro Impresión bajo demanda
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product.
Publicado por Springer Berlin Heidelberg, 2011
ISBN 10: 3642742742ISBN 13: 9783642742743
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Libro
Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.
Publicado por Springer, 2012
ISBN 10: 3642742742ISBN 13: 9783642742743
Librería: Revaluation Books, Exeter, Reino Unido
Libro
Paperback. Condición: Brand New. reprint edition. 240 pages. 9.40x6.80x0.60 inches. In Stock.
Publicado por Springer, 2011
ISBN 10: 3642647626ISBN 13: 9783642647628
Librería: booksXpress, Bayonne, NJ, Estados Unidos de America
Libro
Soft Cover. Condición: new.
Publicado por Springer, 2011
ISBN 10: 3642647626ISBN 13: 9783642647628
Librería: Lucky's Textbooks, Dallas, TX, Estados Unidos de America
Libro
Condición: New.
Publicado por Springer, 2011
ISBN 10: 3642647626ISBN 13: 9783642647628
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Libro Impresión bajo demanda
Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Publicado por Springer Berlin Heidelberg, 2011
ISBN 10: 3642647626ISBN 13: 9783642647628
Librería: moluna, Greven, Alemania
Libro Impresión bajo demanda
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety? In April 1990, this question .
Publicado por Springer Berlin Heidelberg, 2011
ISBN 10: 3642647626ISBN 13: 9783642647628
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Libro
Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - As the focus on pharmaceuticals has broadened from concern for their cost and effectiveness to their real and potential risks and benefits, a critical question has been raised: whose responsibility is it to improve drug safety In April 1990, this question became the theme for a conference at Wolfsberg, Switzerland, near the shores of Lake Constance. Called an 'international dialogue conference' by its organizers, the meeting brought together leaders from the pharmaceutical industry, regulatory authorities, academia, medicine, consumer organizations and the media. Opening addresses were given by representatives of the Council for International Organizations of Medical Sciences (CIOMS), the International Federation of Pharmaceutical Manufacturers Associations (IFPMA), the Swiss International Pharmaceutical Agency, and the RAD-AR Consortium. This book documents the papers presented and discussions held at this conference, which took the topic of risks and benefits of drug therapy one step further to responsibility. It includes a rich menu of issues for those who care about the evaluation of drug therapy, the ethics behind it, the expectations of the patient, and the role of traditional and nontraditional drug safety communica tions. The ideas expressed here come from different parts of the world but relate to common drug safety problems, observations, and scientific assessments; they provide insights into innovative approaches, cautious changes, and desired actions. The papers in this volume are broadly divided into conceptual perspectives (ethics, how the knowledge about drug risks and benefits is generated and appraised, the expectations in drug safety) and operational perspectives (communication, discussion, and action).
Publicado por Springer, 2011
ISBN 10: 3642742742ISBN 13: 9783642742743
Librería: dsmbooks, Liverpool, Reino Unido
Libro
Paperback. Condición: Like New. Like New. book.
Publicado por Springer, 2012
ISBN 10: 3642647626ISBN 13: 9783642647628
Librería: Revaluation Books, Exeter, Reino Unido
Libro
Paperback. Condición: Brand New. reprint edition. 359 pages. 9.53x0.82x6.69 inches. In Stock.
Publicado por Springer, 2011
ISBN 10: 3642647626ISBN 13: 9783642647628
Librería: dsmbooks, Liverpool, Reino Unido
Libro
Paperback. Condición: Like New. Like New. book.